Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19

NCT04537806 is registered in ClinicalTrials.gov with Sage Therapeutics as lead sponsor.

NCT NCT04537806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
Lead sponsor
Sage Therapeutics
Phase
Phase 3
Overall status
Terminated
Start date
December 18, 2020
Completion date
July 1, 2021
Enrollment
29 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19